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A B S T R A C T
A 1-day fear memory in ethanol withdrawn (ETOH) rats is resistant to destabilization-reconsolidation process.
However, d-cycloserine (DCS) reverts this disturbance. Considering that the formation of pathological fear mem-
ories in humans often occurs long time before the requirement of an intervention, the study of older memories is
relevant in ETOH rats. In addition, the resistance to destabilization and DCS effect on this memory phase at mol-
ecular level in ETOH rats have not been corroborated yet. Firstly, we examined the effect of a pharmacological
intervention after reactivation on reconsolidation of a 7-day fear memory in ETOH rats. Then, and considering
that enhanced GluN2B expression and ubiquitin-proteasome system (UPS) activity are involved in destabiliza-
tion, we evaluated them following reactivation in ETOH rats. Furthermore, DCS effect on such destabilization
markers was examined. It was found that the pharmacological intervention after reactivation did not affect the
7-day fear memory in ETOH rats with DCS reversing this resistance. Memory reactivation increased GluN2B ex-
pression, polyubiquitination levels and proteasome activity in the basolateral amygdala complex (BLA) of control
(CON) rats only; without affecting these molecular events in ETOH rats. Finally, ETOH rats treated with DCS
and CON animals displayed elevated and similar UPS activities in the BLA after reactivation. In conclusion, the
reactivation of an older fear memory formed during ethanol withdrawal does not trigger the molecular events
associated with destabilization, and DCS facilitates this memory phase by enhancing the UPS activity.
1. Introduction
Under certain conditions, the reactivation of consolidated memories
can induce a transient labile phase followed by a re-stabilization pe-
riod, referred to as reconsolidation (Alberini, 2005; Nader et al., 2000;
Tronson and Taylor, 2007). Memory destabilization involves protein
degradation whereas memory reconsolidation requires new protein syn-
thesis. The administration of pharmacological and non-pharmacological
interventions during this unstable phase can impair the reconsolidation
process, thereby affecting the original memory trace. Thus, memory re-
consolidation disruption has been tentatively suggested to be a thera-
peutical strategy for weakening memories associated with psychiatric
disorders (Tronson and Taylor, 2013).
It has been observed that fear memory recall promotes an increase
in the alcohol intake in ethanol dependent rats (Bertotto et al., 2010),
indicating a possible role of aversive memories in the maintenance
of alcoholism. Fear memory in ethanol withdrawn (ETOH) animals is
persistent, robust and resistant to extinction (Bertotto et al., 2006).
Moreover, 1-day fear memory is less susceptible to Propranolol (PROP)
disruption after reactivation in ETOH rats, indicat
ing a resistance to the destabilization-reconsolidation process (Ortiz et
al., 2015; Ortiz et al., 2016). Behavioral findings demonstrated that
pre-retrieval D-cycloserine (DCS; a partial agonist of the glycine recog-
nition site of the NMDA receptor) administration promotes the desta-
bilization of resistant memories, including fear memory in ETOH rats
(Bustos et al., 2010; Gazarini et al., 2014; Ortiz et al., 2015; Ortiz et al.,
2016).
From a clinical perspective, it is more relevant to determine the
effectiveness of a treatment for the attenuation of older than recent
aversive memories, because the formation of pathological fear memo-
ries often occurs long time before the appearance of the symptoms re-
quiring an intervention. Accordingly, the study of an older fear mem-
ory in ETOH rats would provide evidence with major impact in the
clinical context. It has been reported that memory processing is al-
tered with the passage of time in both physiological and pathologi-
cal conditions (An et al., 2017; Bustos et al., 2010; Finnie and Nader,
2012; Inda et al., 2011; Wang et al., 2009). Related to this, the re-
sistance to reconsolidation interference of a fear memory in stressed
rats becomes more evident in older (7 and 21-day) than recent (1-day)
memories (Bustos et al., 2010). However, DCS restores the vulnera-
bility to disruption following reactivation of a 7-day fear memory in
stressed rats (Bustos et al., 2010). Thus, a resistance to reconsolida
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tion disruption could be expected in a 7-day fear memory in ETOH rats
which could be rescued by DCS.
Pharmacological and molecular findings have suggested that the
destabilization phase of an aversive memory involves an increase in pro-
tein degradation by the ubiquitin-proteasome system (UPS), evidenced
as enhanced polyubiquitinated protein levels and proteasome activity
in the amygdala (Jarome et al., 2016; Jarome et al., 2011). It has
been suggested that this mechanism is dependent on the activation of
NMDA receptors containing the GluN2B subunit [NMDA-R (GluN2B)]
(Ben Mamou et al., 2006; Jarome and Helmstetter, 2013; Li et al., 2013;
Milton et al., 2013). Related to this, an enhanced GluN2B subunit ex-
pression in the basolateral amygdala complex (BLA) was associated with
the labilization memory phase (Espejo et al., 2016). To date, the resis-
tance to memory destabilization in ETOH rats at molecular level has not
been investigated.
Intra-BLA Propranolol (PROP) infusion is not efficient at disrupting
memory reconsolidation in ETOH rats, but pre-reactivation DCS admin-
istration facilitates the PROP effect, suggesting that NMDA receptors,
potentially in the BLA, are involved in the resistance to memory desta-
bilization-reconsolidation observed in these animals (Ortiz et al., 2015).
Accordingly, it may be predicted that fear memory reactivation does not
trigger the destabilization molecular events in the BLA of ETOH rats.
The role of DCS as a facilitator of destabilization phase in resistant
memories (Bustos et al., 2010; Espejo et al., 2016; Gazarini et al., 2014;
Ortiz et al., 2015; Ortiz et al., 2016) was only evidenced by pharma-
cological studies. Hence, we considered it important to examine the ef-
fect of pre-reactivation DCS administration on destabilization molecular
markers. DCS increases the activation probability of NMDAR and it has
been indicated that DCS favors memory extinction through proteasome
activity (Mao et al., 2008). Hence, it could be expected that DCS facili-
tates destabilization through an increase in the UPS activity.
Considering the above, our first goal was to evaluate the vulnera-
bility to post-reactivation interference of a 7-day fear memory in ETOH
animals. Next, we examined the GluN2B subunit expression, polyubiqui-
tination levels and proteasome activity in the BLA of ETOH animals af-
ter reactivation. Finally, we evaluated the polyubiquitination levels and
proteasome activity in the BLA of ETOH animals treated with DCS be-
fore reminder.
2. Materials and methods
2.1. Animals and chronic ethanol administration
Adult male Wistar rats were maintained in a 12-h light-dark cycle
(lights on at 0700) at a room temperature of 21–22 °C, with food and
water available ad libitum except when detailed otherwise in the pro-
tocol. Animals were housed in groups of 2–4 per cage and habituated
to housing conditions and experimenter handling for 1week before the
start of the experiments. Separate groups of rats were used for each ex-
periment, with animals being randomly assigned to the treatments, drug
injections and behavioral tests. All testing took place between 10:00
and 13:00h, and the experiments were performed by a person who
was blind to the experimental conditions of the animals. The protocols
used were approved by the Animal Care Committee of the Facultad de
Ciencias Químicas, Universidad Nacional de Córdoba, and are consis-
tent with the NIH Guide for the Care and Use of Laboratory Animals.
Rats were made dependent on ethanol by administration of 6% (v/v) of
ethanol in a nutritionally complete liquid diet (Ensure, chocolate flavor,
Abbott Laboratories B.V.), as previously described (Ortiz et al., 2015).
Control (CON) animals were pair-fed with the same diet, but with dex-
trose substituted isocalorically for ethanol. After 14days, the liquid diet
administration was interrupted and animals were subsequently fed with
laboratory chow.
2.2. Drug administration
DL-Propranolol hydrochloride (PROP) and D-cycloserine (DCS)
(Sigma-Aldrich, St. Louis, MO, USA) were both dissolved in saline
(SAL, 0.9% w/v)
at concentrations of 10mg/ml and 5mg/ml, respectively, for i.p. injec-
tion (Ortiz et al., 2015; Ortiz et al., 2016). The total volume of drug used
or an equivalent amount of SAL was 1.0ml/kg.
2.3. Contextual fear conditioning
Contextual fear conditioning (FC) took place in standard training
chambers as previously described (Ortiz et al., 2015). Three days af-
ter interruption of the diet treatment, rats were individually placed
in the chamber and after 3min received 3 unsignaled scrambled foot-
shocks (0.5mA of 3 s duration with a 30s intershock interval). Animals
were kept in the chamber for an additional 50 s, before being imme-
diately brought back to the colony room. Memory reactivation session
(retrieval) took place 1week after learning, and consisted of re-expos-
ing rats to the training context for 5min without shock delivery. The
memory retention test (Test) was performed 1day after reactivation and
consisted of re-exposing rats to the training context for 5min without
shock delivery. The freezing response of each rat was scored during the
reactivation and testing sessions. The total time spent freezing in each
period was quantified (in seconds) manually using a stopwatch. Freez-
ing, a commonly used index of fear in rats (Blanchard and Blanchard,
1969), was defined as the total absence of body and head movement
except that associated with breathing. Freezing was scored by a person
who was unaware of the experimental conditions of each animal. As the
fear training protocol employed induced a similar freezing response in
both the CON and ETOH groups, we discarded the possibility that the
potential differences obtained in the experiments were dependent on the
expression of freezing (Ortiz et al., 2015; Ortiz et al., 2016).
2.4. Tissue processing
Rats were euthanized by decapitation and brains were quickly re-
moved. The bilateral BLA was dissected from coronal brain slices of
2mm using an acrylic brain matrix (Stoelting CO.) on ice. According
to the BLA boundaries defined by Paxinos and Watson (2009), BLA en-
riched tissue being collected using a 2mm micro punch under a magni-
fying glass. Lysis buffer (25mM HEPES; 0.5M NaCl; 2mM EDTA; 1mM
DTT; 0.1% NP40) with protease and phosphatase inhibitors (1mM or-
thovanadate; 1mM PMSF; 10μg/ml leupeptin; 10μg/ml aprotinin; 1μg/
ml pepstatin) were added to the BLA samples, and the tissue was dis-
rupted by brief sonication and centrifuged at 20000g for 2min at 4 °C
(Espejo et al., 2016). The supernatants were stored at −70 °C until use
and protein yield was quantified using the Bradford assay (Biorad).
2.5. Western blot
The samples were combined with sample buffer (50% Glycerol; 4%
SDS; 125mM Tris pH6.8; 400mM DTT; 0.02% bromophenol blue) and
boiled at 100 °C for 5min. Protein samples (40μg for polyubiquitinated
protein or 15μg for GluN2B subunit) were separated on 7.5% SDS
-polyacrylamide gel electrophoresis (PAGE), transferred to nitrocellu-
lose membranes as previously described (Bertotto et al., 2011), and
blocked for 1h. To evaluate polyubiquitinated protein expression, we
used an antibody that recognizes lysine-K48 linked ubiquitin chains
(anti-Ubiquitin-lys-k48, Millipore), which are degradation-specific
polyubiquitin tags (Jarome et al., 2011). Blots were incubated with
anti-Ubiquitin-lys-k48 (1:750, Millipore), followed by incubation with
horseradish peroxidase–conjugated secondary antibody. Actin (Sigma)
was used as a loading control and the obtained film samples were
scanned. To examine the GluN2B subunit, blots were incubated with an
antibody anti-GluN2B subunit (1:750; Cell Signaling Technology), fol-
lowed by incubation with IRDye® 800 WC Donkey Anti-Rabbit IgG.
Tubulin (Sigma) was used as a loading control. The bands were visual-
ized by scanning using an LI-COR Odyssey imager. All images were an-
alyzed by the Gelpro31 program.
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2.6. Proteasome assays
The chymotrypsin-like activity of the proteasome was measured us-
ing the 20S Proteasome Activity Assay Kit (APT280, Millipore; (Werner
et al., 2015)). The reaction was incubated at 37 °C for 120min, and then
the fluorescence was registered at 360 (excitation)/ 460 (emission) on a
monochromatic plate reader (Biotek). Protein free blanks were used and
an AMC standard curve was produced. The unit of chymotrypsin-like ac-
tivity of the proteasome was defined as the pmol of AMC generated per
μg of proteins at 37 °C for 120min.
2.7. Experimental design
2.7.1. Experiment 1
The goal of this experiment was to evaluate the vulnerability to re-
consolidation interference of a 7-day fear memory in ETOH rats. An-
imals from the CON and ETOH groups were fear conditioned as de-
scribed in Materials and Methods. Seven days after training, rats re-
ceived DCS (5mg/kg; i.p.) or SAL 30min before a 5min reactivation ses-
sion. Immediately after, rats were injected with PROP (10mg/Kg, i.p) or
SAL, with memory retention being evaluated the following day (Test).
The experimental design is displayed in Fig. 1a.
2.7.2. Experiment 2
The goal of this experiment was to examine the memory reactivation
effect on the GluN2B subunit expression, polyubiquitination levels and
proteasome activity in the BLA of ETOH rats. Animals from the CON and
ETOH groups were fear conditioned, and 1week later were sacrificed
without a reactivation session (non-reactivated groups, NR) or 60min
after reminder (reactivated groups, R) (Espejo et al., 2016; Jarome et al.,
2011). The expression of the GluN2B subunit and polyubiquitinated pro-
tein were analyzed by Western blot, and the catalytic activity of protea-
some was measured using a commercial kit. The results were expressed
as a percentage of the NR-CON group. The corresponding timelines can
be observed in Figs. 2a, 3a and 4a.
2.7.3. Experiment 3
Here, we evaluated the effect of pre-reminder DCS administration
on protein polyubiquitination and chymotrypsin-like proteasome ac-
tivity in the BLA of ETOH rats. To carry this out, 7days after fear
training ETOH rats were injected with DCS or SAL 30min prior to
memory reactivation and sacrificed one hour later. The results were
expressed as a percentage of reactivated CON (R-CON) rats injected
with SAL before reactivation. These CON rats received
Fig. 1. A 7-day fear memory is not susceptible to reconsolidation disruption in ETOH rats. Effect of d-cycloserine. a- Experimental design. b- Freezing response during reactivation.
c- Freezing levels during memory retention test (n/group: 5). All data are expressed as the mean±SEM. (*) Significantly different from CON-SAL/SAL (p=.002), from CON-DCS/SAL
(p=.0007), from ETOH-SAL/SAL (p=.0003), from ETOH-SAL/PROP (p=.002) and from ETOH-DCS/SAL (p=.0005). (+) Significantly different from CON-SAL/SAL (p=.0007), from
CON-DCS/SAL (p=.0003), from ETOH-SAL/SAL (p=.0002), from ETOH-SAL/PROP (p=.0006) and from ETOH-DCS/SAL (p=.0002). (#) Significantly different from CON-SAL/SAL
(p=.0001), from CON-DCS/SAL (p=.0001), from ETOH-SAL/SAL (p=.0001), from ETOH-SAL/PROP (p=.0001) and from ETOH-DCS/SAL (p=.0001). ETOH: ethanol withdrawn rats.
SAL: saline. DCS: d-cycloserine. PROP: propranolol.
Fig. 2. Fear memory reactivation does not promote an increase of GluN2B subunit expression in the BLA of ETOH rats. a- Experimental design. b- Freezing response during reactivation.
c- GluN2B levels in the BLA. d- Representative blots for GluN2B and tubulin expression (n/group: NR-CON=9; R-CON=10; NR-ETOH=9; R-ETOH=9). All data are expressed as the
mean±SEM. (*) Significantly different from NR-CON (p=.003), from NR-ETOH (p=.042) and from R-ETOH (p=.036). O.D: optical density. FC: fear conditioning. R: reactivated groups.
NR: non-reactivated groups. ETOH: ethanol withdrawn rats. CON: control rats.
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Fig. 3. Fear memory reactivation does not promote an increase in the polyubiquitinated proteins in the BLA of ETOH rats. a- Experimental design. b-Freezing response during reactiva-
tion. c- Polyubquitinated protein expression in the BLA. d- Representative blots for polyubquitinated proteins and actin (n/group: NR-CON=7; R-CON=8; NR-ETOH=7; R-ETOH=7).
All data are expressed as the mean±SEM. (*) Significantly different from NR-CON (p=.0007), from NR-ETOH (p=.031) and from R-ETOH (p=.001). O.D: optical density. FC: fear
conditioning. R: reactivated groups. NR: non-reactivated groups. Polyubq: polyubiquitinated. ETOH: ethanol withdrawn rats. CON: control rats.
Fig. 4. Fear memory reactivation does not increase the chymotrypsin-like proteasome
activity in the BLA of ETOH rats. a- Experimental design. b-Freezing response dur-
ing reactivation. c- Proteasome activity in the BLA (n/group: NR-CON=7; R-CON=7;
NR-ETOH=7; R-ETOH=7). All data are expressed as the mean±SEM. (*) Signifi-
cantly different from NR-CON (p=.002), from NR-ETOH (p=.005) and from R-ETOH
(p=.0002). FC: fear conditioning. R: reactivated groups. NR: non-reactivated
groups. ETOH: ethanol withdrawn rats. CON: control rats.
the liquid diet, training and reminder at the same time that ETOH
groups. The experimental design is shown in Fig. 5a.
Several behavioral findings have indicated that the facilitating effect
of DCS on the destabilization process in resistant memories is dependent
on the reactivation session, and that this drug does not affect this mem-
ory phase in CON rats (Espejo et al., 2016; Gazarini et al., 2014; Ortiz
et al., 2015; Ortiz et al., 2016). Moreover, Espejo et al. (2016) reported
that CON animals treated with SAL or DCS before memory reactivation
showed similar expressions of Zif-268, indicating that DCS in CON rats
does not modify the expression of this transcription factor in the recon-
solidation process. Therefore, to minimize the number of animals used,
neither the NR groups nor the R-CON rats treated with DCS were in-
cluded in the experimental designs.
2.8. Statistical analyses
Results were expressed as the mean±S.E.M, and the data were an-
alyzed by the student's t-test or ANOVAs followed by the Tukey's HSD
post-hoc test (p<.05 was regarded as significant). Each animal was only
used once.
3. Results
Experiment 1: A 7-day fear memory is not susceptible to reconsoli-
dation disruption in ethanol withdrawn rats. Effect of D-cycloserine.
As can be observed in Fig. 1c, CON animals injected with PROP
showed decreased freezing levels, regardless of the pre-reactivation
treatment. Moreover, PROP was ineffective at reducing the fear re-
sponse in ETOH rats that received a pre-reactivation SAL injection.
However, ETOH animals treated with DCS-PROP showed a decreased
freezing response that did not differ from those shown by the
CON-PROP groups. ANOVA revealed significant diet treatment x pre-re-
activation drug x post-reactivation drug interactions for memory reten-
tion test [F(1,32)=6.67; p<.05]. Tukey's test revealed that freezing
levels of DCS-PROP and SAL-PROP from the CON group and DCS-PROP
from the ETOH group did not differ from each other and were signifi-
cantly lower than the remaining groups. Nevertheless, regardless of the
pre-reactivation treatment, all rats showed similar fear responses during
the reactivation session [F(1,32)=0.17; p>.05] (Fig. 1b).
Experiment 2: Fear memory reactivation does not increase GluN2B
subunit expression or UPS activity in the BLA of ETOH rats.
Memory reactivation increased the GluN2B subunit expression,
polyubiquitinated protein expression and chymotrypsin-like proteasome
activity in the BLA but only in CON rats (Figs. 2c, 3c and 4c, respec-
tively). The protein levels and enzymatic activity were similar and com-
parable between R-ETOH rats and non-reactivated groups. A two-way
ANOVA indicated a significant diet treatment x reactivation interac-
tion for GluN2B [F(1,33)=7.39; p<.05], polyubiquitinated protein
expression [F (1,25)=17.57, p<.05] and proteasome activity [F
(1,24)=17.31, p<.05]. Furthermore, Tukey's test revealed that the
reactivated CON animals exhibited a significantly greater expression
of the GluN2B subunit (Fig. 2c), polyubiquitination (Fig. 3c) and en-
zymatic proteasome activity (Fig. 4c) in the BLA than the remaining
groups. As expected, CON and ETOH animals displayed equivalent lev-
els of freezing during fear recall ([t=0.10; df=17; p>.05], Fig. 2b;
[t=−1.84; df=13; p>.05], Fig. 3b; [t=−0.34; df=12; p>.05], Fig.
4b).
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Fig. 5. D-cycloserine restores the enhancement of the polyubiquitinated proteins and proteasome activity in the BLA following reactivation in ETOH rats. a- Experimental design. Polyu-
biquitination experiment: b- Freezing response during reactivation. c- Polyubiquitinated protein levels in the BLA. d- Representative blots for polyubiquitinated proteins and actin (n/
group: R-CON=7; ETOH-SAL=6; ETOH-DCS=6). (*) Significantly different from R-CON (p=.030) and from ETOH-DCS (p=.043). Proteasome activity experiment: e- Freezing re-
sponse during reactivation. f- Proteasome activity in the BLA (n/group: R-CON=6; ETOH-SAL=8; ETOH-DCS=7). All data are expressed as the mean±SEM. (*) Significantly different
from R-CON (p=.018) and from ETOH-DCS (p=.006). ETOH: ethanol withdrawn rats. FC: fear conditioning. SAL: saline. DCS: d-cycloserine. O.D: optical density. Polyubq: polyubiquiti-
nated. R-CON: control rats submitted to a reactivation session injected with saline.
Experiment 3: Pre-reactivation d-cycloserine administration restores
the enhancement of protein polyubiquitination and proteasome activity
in the BLA of ETOH rats.
Fig. 5c and f show that animals from the ETOH-SAL group exhib-
ited decreased UPS activity, while R-CON and ETOH-DCS groups dis-
played elevated and similar UPS activity. One-way ANOVA indicated
a significant effect of experimental condition (CON-SAL vs ETOH-SAL
vs ETOH-DCS) for polyubiquitination levels [F (1,16)=5.00, p<.05]
and enzymatic activity [F (1,18)=7.57, p<.05]. Tukey's tests revealed
that ETOH-SAL group exhibited significantly lower polyubiquitinated
protein expression and proteasome activity than R-CON and ETOH-DCS
groups which did not differ between them. In addition, all animals
displayed similar fear responses during the reactivation session ([F
(1,16)=1.21, p>.05] Fig. 5b; [F (1,18)=1.21, p>.05] Fig. 5e).
4. Discussion
As expected, we found that PROP administration following reacti-
vation of a 7-day memory did not reduce the fear response in a subse-
quent memory test in ETOH rats. However, pre-reactivation DCS injec-
tion promoted the vulnerability to the PROP disruptive effect on recon-
solidation in these animals. Moreover, and in accordance with previous
results (Bustos et al., 2010), we observed that a 7-day fear memory in
CON rats is vulnerable to reconsolidation interference. In conclusion, a
limited dynamic after reactivation is observed in an older fear memory
in ETOH rats. This evidence highlights a possible limitation for clinical
interventions for the interference with the reconsolidation. As an alter-
native approach, we suggest that DCS/PROP administration in conjunc-
tion with memory reactivation could be an effective treatment to atten-
uate older fear memories involved in psychiatric disorders.
A resistance to PROP's interference of a fear memory and its rever-
sion by DCS in ETOH rats has been only reported 1day after training
(Ortiz et al., 2015), here we extended this phenomenon at least up to
1week post-learning. Furthermore, since the attenuation of a fear mem-
ory 24h after learning has a limited application in humans, our present
findings provide evidence with major impact in the clinical context.
In agreement with other studies (Espejo et al., 2016; Jarome et al.,
2016; Jarome et al., 2011), fear memory reactivation increased the
GluN2B subunit, polyubiquitinated proteins and proteasome activity in
the BLA of CON rats. However, no differences were detected between
R-ETOH animals and non-reactivated groups. The fact that ETOH ani-
mals displayed similar patterns to those observed in the NR-CON group
discards a possible effect of ethanol withdrawal per se on the studied
proteins. Thus, fear memory reactivation did not trigger the intracellular
mechanisms in the BLA involved in the destabilization phase in ETOH
animals.
There is little information available related to the mechanisms in-
volved in the resistance to reconsolidation disruption of a fear mem-
ory. Wang et al. indicated that a resistant memory induced by a strong
training is associated with decreased GluN2B levels in the BLA 2days
after fear learning (Wang et al., 2009). Therefore, it might be expected
that NR-ETOH animals have less GluN2B expression with respect to
NR-CON rats. However no such difference was found in the present
study. This apparent discrepancy may have been due to the proto-
col used in generating a fear memory resistant to labilization (ethanol
withdrawal vs intensive training), as well as the time at which the
protein expression was evaluated (7days vs 2days, post-conditioning).
In agreement with our results, reactivation of a fear memory resis-
tant to labilization induced by stress did not increase GluN2B sub-
unit expression in the BLA (Espejo et al., 2016). In addition, the re-
sistance to reactivation-dependent memory destabilization is associ-
ated with an increase in the synaptic GluN2A/
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GluN2B ratio in the BLA (Holehonnur et al., 2016). In summary, fear
memory resistance to reconsolidation disruption is associated with an
alteration in NMDA-R (GluN2B) expression in the BLA.
There is evidence that chronic ethanol consumption and withdrawal
induce an increase in the expression of NMDA-R in the hippocampus,
central amygdala and cortex (Krystal et al., 2003; McCool et al., 2010),
although studies in the BLA are scarce. Thus, alcohol dependence does
not alter protein expression or mRNA levels of the GluN2B subunit in
the BLA (Floyd et al., 2004; Obara et al., 2009). Related to this, we did
not find any increase of the GluN2B subunit in the BLA in ETOH animals
that were not subjected to memory reactivation.
Despite alcohol altering the protein degradation processes mediated
by UPS in pathologies such as alcoholic liver disease (Bardag-Gorce et
al., 2011; Osna, 2011), evidence of the effects of ethanol dependence on
UPS activity in the central nervous system is limited. An alteration in
the UPS functioning in the cerebral cortex of mice subjected to ethanol
consumption for 4months was reported (Pla et al., 2014). However,
these findings are not comparable with the present results because here
the UPS activity was evaluated in animals following ethanol withdrawal
and then subjected to contextual fear conditioning. In addition, there
are other differences between both studies, including: 1) the protocol of
chronic consumption (liquid diet vs ethanol in the drinking water), 2)
the duration of consumption (14days vs 4months), 3) the cerebral areas
where the activity of the UPS was evaluated (BLA vs cerebral cortex),
and 4) the animal species (rats vs mice).
Previous findings have indicated that ethanol withdrawal facilitates
the formation of a robust, persistent contextual fear memory that is re-
sistant to extinction (Bertotto et al., 2006). Related to the molecular cor-
relation of this exaggerated emotional response, it was found that al-
cohol dependence induces neuroadaptive changes in the properties or
functioning of NMDA-R, in the activation of ERK protein kinases and
in the expression of c-Fos in the brain structures involved in associa-
tive fear learning, including the BLA (Bertotto et al., 2010; Bertotto et
al., 2011). Moreover, other evidence from our laboratory indicated that
ethanol withdrawal induces a reduction of GABAergic transmission.
n in the BLA projection neurons (Isoardi et al., 2007) and a de-
creased surface expression of α1-containing GABAA receptors (Ortiz et
al., 2015). Such alterations may result in a hyperexcitability in the BLA,
thereby favoring the formation of maladaptive fear memories in ETOH
rats (Bertotto et al., 2006; Isoardi et al., 2007). Considering these and
the present findings, it could be suggested that withdrawal following
chronic ethanol consumption modifies molecular pathways in the BLA,
promoting an altered encoding of fear memory that prevents memory
processing after reactivation.
The role of DCS as facilitator of destabilization of resistant memo-
ries had been only reported through behavioral studies (Espejo et al.,
2016; Gazarini et al., 2014; Ortiz et al., 2015; Ortiz et al., 2016). Here
we found that DCS restored the destabilization molecular events in the
BLA after reactivation of a resistant fear memory in ETOH rats. With re-
spect to this, the polyubiquitination levels and proteasome activity ex-
hibited by ETOH-DCS animals were higher than those expressed in the
ETOH-SAL group. Moreover, the ETOH-DCS group revealed a similar
UPS activity to that observed in CON rats after reactivation. Neverthe-
less, given that we did not study the DCS effects on non-reactivated ani-
mals, we cannot discard the possibility that DCS per se enhances polyu-
biquitination or proteasome enzymatic activity in the BLA. However, it
is important to note that DCS modulation on fear memory instability
is dependent on reactivation (Bustos et al., 2010; Espejo et al., 2016;
Gazarini et al., 2014; Ortiz et al., 2015; Ortiz et al., 2016). Therefore,
we can hypothesize that DCS ability to induce memory destabilization
following reactivation, and in turn, to promote vulnerability to several
disruptive agents may be due to its effect on UPS activity.
Summing up, the present findings indicate that: 1) the resistance
to memory interference after reactivation in ETOH animals can be ob-
served at least up to 7days after training; 2) DCS/PROP treatment in
conjunction with memory reactivation allows disrupting reconsolida-
tion of older memory in ETOH rats; 3) the reactivation of an older
fear memory does not trigger the molecular events
in ETOH rats; and 4) DCS induces the destabilization of a resistant mem-
ory by enhancing the UPS activity.
Effective therapeutic strategies to reduce the influence of maladap-
tive memories in the maintenance of psychiatric disorders are required.
Related to this, our results propose a potential effective pharmacolog-
ical treatment for the attenuation of maladaptive older fear memories
associated with drug addiction and fear-related disorders. Furthermore,
the molecular characterization after memory reactivation in ETOH rats
reported here provides basis to determine in future studies the poten-
tial mechanisms involved in the resistance to destabilization-reconsoli-
dation process.
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